STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 29% Price Jump
Needham Maintains Staar Surgical(STAA.US) With Hold Rating
William Blair Maintains Staar Surgical(STAA.US) With Hold Rating
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $20
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Staar Surgical Analyst Ratings
Morgan Stanley Maintains Staar Surgical(STAA.US) With Sell Rating, Maintains Target Price $13
Express News | STAAR Surgical Co : Canaccord Genuity Raises Target Price to $20 From $17
STAAR Surgical Faces Challenges, Eyes Future Growth
STAAR Surgical Projects Significant China Revenue Rebound in Q3 2025 Amid Tariff Mitigation and New Product Launch
Staar Surgical Pulls Fiscal-Year Outlook on Economic Uncertainty, Tariffs
STAAR Surgical (NASDAQ:STAA) Exceeds Q1 Expectations
12 Health Care Stocks Moving In Wednesday's After-Market Session
STAAR SURGICAL Earnings Results: $STAA Reports Quarterly Earnings
STAAR Surgical Shares Are Trading Lower After the Company Reported Mixed Q1 Financial Results.
Express News | STAAR Surgical Shares Are Trading Lower After the Company Reported Mixed Q1 Financial Results
Staar Surgical Q1 Adj. EPS $(0.64) Misses $(0.59) Estimate, Sales $42.59M Beat $40.30M Estimate
Staar Surgical | 10-Q: Q1 2025 Earnings Report
Staar Surgical: Global Economic Uncertainty and Evolving Tariff Policy Make It More Challenging to Forecast >STAA
Staar Surgical Withdrawing the Fincl Outlook Previously Provided on Feb 11 >STAA